103 R&D activities and industrialization of lutein and zeaxanthin,,,,,, 1 4 () 1 3501000 2 A52 03 09 150 10006354 2005-10-01 2010-12-01 2011454000021683-1 -
1000 Kemin DSM BAC2 90% 80% p- 90% 80% -- 20 3 4 8 FCC7 USP32 FDA GRAS 40223.25 8523.65 4272.78 4006.04 (Pfizer)(B&L) NBTYAIDPSERGENT NUTREX - 2 -
1 BAC2 80% 5 4 ZL200510028396.1 ZL200610026613.8US7271298 B2, EP1857441 B1CN101781240A2-3 US7485738 B2ZL200610053642.3EP1911742B23 -- 12 WO2009/039716A1CN101177540ACN101396068ACN101461450 CN101595977CN101828693AEP09161242.4US12/473464US12/271229EP08168252.8 NO20083794 ( 80%) -- 20 3 4 8 FCC7 USP32 40223.25 8523.65 4272.78 4006.04-3 -
960.00 1 2008 12627.13 3012.04 1031.91 1317.94 0.00 2009 12322.65 2647.85 1346.77 1285.44 0.00 2010 15273.47 2863.76 1894.10 1402.66 0.00 40,223.25 8,523.65 4,272.78 4,006.04 0.00 200 =- = = () 2008 0.00 2009 0.00 2010 0.00 0.00 200-4 -
1 2 3-5 -
330624197001196917 1970-01-01 1992-07-01 057586021462 59 312500 shaob@xcpharma.com 13706852281 2000 " 151 " 2005-10-01 2010-12-01 200 10%-15% - 6 -
- 7 -
- 8 -
- 9 -
- 10 -
- 11 -
- 12 -